Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study

PURPOSE: Erythropoiesis-stimulating agents (ESAs) are often used in treatment of patients with chemotherapy-induced anemia. Many studies have demonstrated an improved hemoglobin (Hb) response when ESA is combined with intravenous iron supplementation and a higher effectiveness of intravenous iron ov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Support Care Cancer
Autors principals: Mafodda, Antonino, Giuffrida, D., Prestifilippo, A., Azzarello, D., Giannicola, R., Mare, M., Maisano, R.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527057/
https://ncbi.nlm.nih.gov/pubmed/28391437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3690-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars